BackAl-Dawaa Medical Services Company Overview

Al-Dawaa Medical Services Company EBIT

Track Al-Dawaa Medical Services Company's EBIT ($330M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$72.38M
↓ 39.53% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$333.16M
↓ 34.49% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Al-Dawaa Medical Services Company (4163.SR) FAQ

As of the most recent data (June 2026), 4163.SR shows a EBIT of $330M. That compares with $510M in the prior-year period — down 34.5% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4163.SR's EBIT is now $330M (was $510M) — a 34.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Al-Dawaa Medical Services Company is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. Al-Dawaa Medical Services Company is at $330M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how 4163.SR stacks up against individual peers as well.

Tracking 4163.SR's ebit over time shows whether Al-Dawaa Medical Services Company is scaling, shrinking, or reshaping that part of the business. The current reading is $330M That compares with $510M in the prior-year period — down 34.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Al-Dawaa Medical Services Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $330M) with ownership activity and broader fundamentals.